TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26227188

Group type: EXPERIMENTAL
Intervention: Routine invasive strategy (coronary arteriography and myocardial revascularization as clinically indicated)
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Selective invasive strategy (coronary arteriography for recurrent ischemia only)
Number of subjects: 1810

Group type: EXPERIMENTAL
Intervention: Routine invasive strategy
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Selective invasive strategy
Number of subjects: 1810

Group type: EXPERIMENTAL
Intervention: Routine invasive strategy and Selective invasive strategy
Number of subjects: 1810
Study: 24284002

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Combined KMC and 24% oral sucrose
Number of subjects: 258

Group type: COMPARATOR
Intervention: 24% oral sucrose alone
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: KMC
Number of subjects: 258
Study: 21827441

Group type: EXPERIMENTAL
Intervention: 1 mcg/kg dexmedetomidine in 100 ml of normal saline over 10 min; 1 mcg/kg/h dexmedetomidine infusion during surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100 ml of normal saline over 10 min; 1 ml/kg/h normal saline infusion during surgery
Number of subjects: 40
Study: 17873492

Group type: EXPERIMENTAL
Intervention: Bosentan (8-125 mg b.i.d.)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 15756179

Group type: EXPERIMENTAL
Intervention: ST graft (semitendinosus tendon)
Number of subjects: 97

Group type: COMPARATOR
Intervention: STG graft (semitendinosus and gracilis)
Number of subjects: 97
Study: 12424933

Group type: EXPERIMENTAL
Intervention: Deferiprone (75 mg/kg/day in 12 hourly divided doses)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard quinine and doxycycline therapy with placebo
Number of subjects: 45
Study: 10360098

Group type: EXPERIMENTAL
Intervention: Royal College of General Practitioners' mobility screening questionnaire
Number of subjects: 627
Study: 8955576

Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 27
Study: 1834440

Group type: EXPERIMENTAL
Intervention: Bolus dose of ANF 100 micrograms
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Infusion of ANF 50 micrograms at 1.67 micrograms/min for 30 min
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 7070987

Group type: EXPERIMENTAL
Intervention: Propranolol administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin administration
Number of subjects: 0
Study: 31775999

Group type: EXPERIMENTAL
Intervention: CFR‐PEEK
Number of subjects: 76

Group type: COMPARATOR
Intervention: Titanium
Number of subjects: 76
Study: 28003178

Group type: EXPERIMENTAL
Intervention: Families for Health (FFH)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 115
Study: 26096582

Group type: EXPERIMENTAL
Intervention: Robot-assisted intervention with Paro (30 minutes twice a week for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with treatment as usual
Number of subjects: 60
Study: 24924267

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid spray (two pumps, three times daily for 7 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Benzydamine hydrochloride spray (two pumps, three times daily for 7 days)
Number of subjects: 34
Study: 22876063

Group type: EXPERIMENTAL
Intervention: CRAB bacteremia patients
Number of subjects: 106
Study: 19317300

Group type: EXPERIMENTAL
Intervention: Prolonged heparin infusion
Number of subjects: 200

Group type: COMPARATOR
Intervention: No post-procedural heparin (control group)
Number of subjects: 200
Study: 17503991

Group type: EXPERIMENTAL
Intervention: Quetiapine (mean endpoint dose = 460 ± 88 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 20
Study: 16036037

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 2
Study: 11605083

Group type: EXPERIMENTAL
Intervention: WS1490 (kava-kava special extract)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9040574

Group type: EXPERIMENTAL
Intervention: Treated hypertensive (n = 207)
Number of subjects: 1651

Group type: EXPERIMENTAL
Intervention: Untreated hypertensive (n = 402)
Number of subjects: 1651

Group type: COMPARATOR
Intervention: Normotensive (n = 1042)
Number of subjects: 1651

Group type: EXPERIMENTAL
Intervention: Home and 24 h blood pressures (treated and untreated hypertensives)
Number of subjects: 1651

Group type: EXPERIMENTAL
Intervention: Day and night average blood pressures (treated and untreated hypertensives)
Number of subjects: 1651

Group type: EXPERIMENTAL
Intervention: Overall hypertensive population
Number of subjects: 1651
Study: 7701806

Group type: EXPERIMENTAL
Intervention: BC1 (buffy coat platelet concentrates filtered prior to storage)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: BC3 (buffy coat platelet concentrates filtered after 3-4 days' storage)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard platelet-rich plasma (PRP) PCs
Number of subjects: 86

Group type: COMPARATOR
Intervention: Leukocyte-depleted PRP PCs
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: BC1 PCs
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: BC3 PCs
Number of subjects: 86
Study: 2980999

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28388850

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 31393279

Group type: EXPERIMENTAL
Intervention: Ground-based walking training (GBWT)
Number of subjects: 95
Study: 29187230

Group type: EXPERIMENTAL
Intervention: Personalized music
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-personalized relaxing music
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 60
Study: 25342388

Group type: EXPERIMENTAL
Intervention: One-year aerobic and strength exercise intervention (150 min/week)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 189
Study: 23512956

Group type: EXPERIMENTAL
Intervention: 1,000 kcal/day
Number of subjects: 125

Group type: COMPARATOR
Intervention: 1,500 kcal/day
Number of subjects: 125
Study: 21502288

Group type: EXPERIMENTAL
Intervention: Lengthening MVCs
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isometric MVCs
Number of subjects: 12
Study: 18970943

Group type: EXPERIMENTAL
Intervention: Nonrigid fixation using sutures
Number of subjects: 16

Group type: COMPARATOR
Intervention: Rigid fixation using titanium or resorbable osteosynthesis plates
Number of subjects: 16
Study: 16946074

Group type: EXPERIMENTAL
Intervention: Social-psychological intervention (brief in-class writing assignment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 12742491

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard stent
Number of subjects: 238
Study: 10573546

Group type: EXPERIMENTAL
Intervention: Extra-virgin olive oil (VO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Refined olive oil (RO)
Number of subjects: 24
Study: 8733734

Group type: EXPERIMENTAL
Intervention: Conditioned stimulus displayed on a screen for 2 s followed by an unconditioned electric shock to the right middle finger.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control stimulus not paired with a shock.
Number of subjects: 4
Study: 1862732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 6841187

Group type: EXPERIMENTAL
Intervention: Remotely controlled high-dose-rate intracavitary radiotherapy (30 Gy for high-dose-rate group by 3 fractions with a once a week schedule)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Manual afterloading low-dose-rate therapy (40-60 Gy with one or two fractions)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Both groups (high-dose-rate and low-dose-rate)
Number of subjects: 249
Study: 30620767

Group type: EXPERIMENTAL
Intervention: Clinical trials with new anticancer biological agents
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Clinical trials with immunotherapeutic drugs
Number of subjects: 9
Study: 31676222

Group type: EXPERIMENTAL
Intervention: Odanacatib (50 mg once per week)
Number of subjects: 16071

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16071

Group type: EXPERIMENTAL
Intervention: Odanacatib
Number of subjects: 16071
Study: 28687275

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula (n = 113)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional formula (control, n = 117)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional formula
Number of subjects: 230
Study: 26564281

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (100-200mg daily)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Letrozole (2.5-5mg daily)
Number of subjects: 75
Study: 23423539

Group type: EXPERIMENTAL
Intervention: Single-TENS group (STG) with one active and one placebo TENS (n = 13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Dual-TENS group (DTG) with both active TENS devices applied at the low back and cervical areas
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Single-TENS group (STG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Dual-TENS group (DTG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison among groups (DTG vs STG vs PG)
Number of subjects: 39
Study: 22416600

Group type: EXPERIMENTAL
Intervention: Terumo Capiox FX05 oxygenator with integrated arterial filter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Terumo Capiox RX05 Baby oxygenator and arterial filter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined FX and RX groups
Number of subjects: 40
Study: 19073905

Group type: EXPERIMENTAL
Intervention: Energy deficit (DEF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Energy balance (BAL)
Number of subjects: 18
Study: 16428551

Group type: EXPERIMENTAL
Intervention: Nimodipine 30 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15622019

Group type: COMPARATOR
Intervention: Dichotic listening in nondirected attention condition
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dichotic listening in directed attention conditions
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dichotic listening measures related to handedness
Number of subjects: 46

Group type: COMPARATOR
Intervention: Perceptual errors in nondirected attention condition
Number of subjects: 46
Study: 11501363

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 40
Study: 9550532

Group type: EXPERIMENTAL
Intervention: Exercise training (50% to 75% maximal O2 consumption [VO2max], 200 to 300 kcal/session) 4 d/wk for 12 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 37
Study: 7931231

Group type: EXPERIMENTAL
Intervention: Deprenyl (10 mg per day for 12 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (for 12 weeks)
Number of subjects: 10
Study: 3146506

Group type: EXPERIMENTAL
Intervention: Oral co-dergocrine (8.0 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous co-dergocrine (0.9 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both intravenous and oral doses
Number of subjects: 12
Study: 31977270

Group type: EXPERIMENTAL
Intervention: D-index-guided early antifungal therapy (DET)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Empiric antifungal therapy (EAT)
Number of subjects: 423
Study: 31246564

Group type: EXPERIMENTAL
Intervention: Postpartum IUD counseling for Sinhalese women who speak only Sinhala
Number of subjects: 4497

Group type: COMPARATOR
Intervention: Postpartum IUD counseling for women who speak both Sinhala and Tamil
Number of subjects: 4497

Group type: COMPARATOR
Intervention: Postpartum IUD counseling for women who speak only Tamil
Number of subjects: 4497
Study: 26630216

Group type: EXPERIMENTAL
Intervention: Lercanidipine 10 or 20 mg daily
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Enalapril 10 or 20 mg daily
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Lercanidipine-Enalapril combination treatment
Number of subjects: 854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 854
Study: 25519464

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (58.5 mg/mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline (9 mg/mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both hypertonic and isotonic saline
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 30
Study: 23563904

Group type: EXPERIMENTAL
Intervention: Fibrin sealant VH S/D 4 s-apr (Artiss)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) treatment
Number of subjects: 75
Study: 20674480

Group type: EXPERIMENTAL
Intervention: 7% carbon dioxide inhalation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 10
Study: 18452447

Group type: EXPERIMENTAL
Intervention: Psychoeducation group intervention for caregivers
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 113
Study: 16548733

Group type: EXPERIMENTAL
Intervention: PlasmaKinetic (PK) Superpulse system
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional transurethral resection of the prostate (TURP)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 105
Study: 12900064

Group type: EXPERIMENTAL
Intervention: 6h retest group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1-week retest group
Number of subjects: 50
Study: 10746484

Group type: EXPERIMENTAL
Intervention: Trandolapril 4 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8770673

Group type: EXPERIMENTAL
Intervention: Surgical correction of VPI after normal articulation placement, N=14
Number of subjects: 29

Group type: COMPARATOR
Intervention: Speech therapy aimed to correct CA, N=15
Number of subjects: 29
Study: 1579938

Group type: EXPERIMENTAL
Intervention: Piroxicam (40 mg preoperatively, 40 mg on the day of surgery, 20 mg on days 1 and 2)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 7398988

Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone valerate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.01% hydrocortisone 17‐butyrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids applied after irradiation (betamethasone and hydrocortisone)
Number of subjects: 0
Study: 31417163

Group type: EXPERIMENTAL
Intervention: Neuraminidase inhibitors (NAIs)
Number of subjects: 0
Study: 27605365

Group type: EXPERIMENTAL
Intervention: Standard care (SC) + Text Messaging (TM) + Adherence-focused Behavioral Therapy (ABT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 158
Study: 25990891

Group type: EXPERIMENTAL
Intervention: CMS non-payment policy
Number of subjects: 4080000
Study: 23949576

Group type: EXPERIMENTAL
Intervention: 2 liters of PEG‐EL with 1 liter of pineapple juice (Dimes 100%)
Number of subjects: 126

Group type: COMPARATOR
Intervention: 4 liters of PEG‐EL
Number of subjects: 126

Group type: COMPARATOR
Intervention: 2 liters of PEG‐EL
Number of subjects: 126
Study: 21193066

Group type: EXPERIMENTAL
Intervention: Community-wide isoniazid preventive therapy (IPT) offered to all employees
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine IPT targeted to those identified as at higher risk of TB (due to HIV infection or silicosis)
Number of subjects: 0
Study: 20214205

Group type: EXPERIMENTAL
Intervention: 20% Albumin 100 ml every 12 hours
Number of subjects: 56

Group type: COMPARATOR
Intervention: 6% hydroxyethylstarch 250 ml every 6 hours
Number of subjects: 56
Study: 17975450

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (energy conservation course)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Delayed control group
Number of subjects: 169
Study: 16632238

Group type: EXPERIMENTAL
Intervention: Gliclazide (160 mg daily for 4 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Glibenclamide (5 mg daily for 4 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Gliclazide and Glibenclamide (both treatments)
Number of subjects: 13
Study: 12730416

Group type: EXPERIMENTAL
Intervention: +ISO (soy protein with 83 mg isoflavones)
Number of subjects: 150

Group type: COMPARATOR
Intervention: -ISO (soy protein with 3 mg isoflavones)
Number of subjects: 150
Study: 9926947

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated tibial components
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cemented tibial components
Number of subjects: 53
Study: 7591860

Group type: EXPERIMENTAL
Intervention: Paced calculating task at overload levels (above 100% workload)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Paced calculating task at various workloads
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Paced calculating task
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Paced calculating task over time
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Oz beta 2 amplitudes and critical flicker frequency
Number of subjects: 41
Study: 1689679

Group type: EXPERIMENTAL
Intervention: Surgical biliary bypass followed by synchronous therapy (10 intravenous administrations of 5-fluorouracil 750 mg/m2 over 8 h, followed by radiation with 400 rads every 4 days) in Group 1.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Synchronous therapy (10 intravenous administrations of 5-fluorouracil 750 mg/m2 over 8 h, followed by radiation with 400 rads every 4 days) in Group 2.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Synchronous therapy (10 intravenous administrations of 5-fluorouracil 750 mg/m2 over 8 h, followed by radiation with 400 rads every 4 days) in both groups.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Surgical palliation (surgical biliary bypass) in nonresectable pancreatic carcinoma.
Number of subjects: 92
Study: 6987582

Group type: EXPERIMENTAL
Intervention: 500 mg potassium penicillin or erythromycin ethylsuccinate q.i.d.
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Control group (no antibiotic treatment)
Number of subjects: 1441
Study: 30653338

Group type: EXPERIMENTAL
Intervention: Ayurvedic diagnosis by 4 Ayurvedic experts
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Consensus ratings
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Disease-related entities
Number of subjects: 30
Study: 29069153

Group type: EXPERIMENTAL
Intervention: Codeine (30 mg) plus acetaminophen (500 mg), every 4 h, for 3 days
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tramadol hydrochloride (37.5 mg) plus acetaminophen (500 mg), every 4 h, for 3 days
Number of subjects: 26
Study: 25599385

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combined Training (CT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 65
Study: 23334613

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study: 21982651

Group type: EXPERIMENTAL
Intervention: Darapladib (160 mg enteric-coated tablet daily)
Number of subjects: 13000

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 13000

Group type: EXPERIMENTAL
Intervention: Darapladib
Number of subjects: 13000
Study: 18387273

Group type: EXPERIMENTAL
Intervention: Drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17249526

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 14563749

Group type: EXPERIMENTAL
Intervention: Daycare place at the centre providing high quality day care
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control families using other child care
Number of subjects: 143
Study: 11023932

Group type: EXPERIMENTAL
Intervention: 150-J biphasic shocks
Number of subjects: 338

Group type: COMPARATOR
Intervention: 200- to 360-J monophasic shocks
Number of subjects: 338
Study: 8779124

Group type: EXPERIMENTAL
Intervention: Long term steroid treatment (group L) for at least 18 months
Number of subjects: 149

Group type: COMPARATOR
Intervention: Selective treatment (group S) reserved for symptoms or deteriorating lung function
Number of subjects: 149
Study: 1501567

Group type: EXPERIMENTAL
Intervention: Group 1: 4186 kJ.d‐1 (1000 kcal.d‐1) with 40% fat, 40% carbohydrate, 20% protein
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group 2: 4186 kJ.d‐1 (1000 kcal.d‐1) with 20% fat, 60% carbohydrate, 20% protein
Number of subjects: 36
Study: 6859300

Group type: EXPERIMENTAL
Intervention: Abstinence therapy
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Controlled drinking with behavior modification
Number of subjects: 625

Group type: COMPARATOR
Intervention: Usual clinic services (Control)
Number of subjects: 625
Study: 31520576

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg single oral dose)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ibuprofen (control)
Number of subjects: 31
Study: 31800420

Group type: EXPERIMENTAL
Intervention: Autologous BPTB graft
Number of subjects: 150

Group type: COMPARATOR
Intervention: Primary repair
Number of subjects: 150

Group type: COMPARATOR
Intervention: LAD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study: 28409743

Group type: EXPERIMENTAL
Intervention: PET-CT-guided surveillance
Number of subjects: 564

Group type: COMPARATOR
Intervention: Planned neck dissection (ND)
Number of subjects: 564
Study: 26966829

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) in combination with counseling and jaw exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Counseling and exercise alone
Number of subjects: 28